94 related articles for article (PubMed ID: 22840497)
1. HIV-1 diseases progression associated with loss of Th17 cells in subtype 'C' infection.
Singh A; Vajpayee M; Ali SA; Mojumdar K; Chauhan NK; Singh R
Cytokine; 2012 Oct; 60(1):55-63. PubMed ID: 22840497
[TBL] [Abstract][Full Text] [Related]
2. Cellular interplay among Th17, Th1, and Treg cells in HIV-1 subtype "C" infection.
Singh A; Vajpayee M; Ali SA; Chauhan NK
J Med Virol; 2014 Mar; 86(3):372-84. PubMed ID: 24249618
[TBL] [Abstract][Full Text] [Related]
3. Long-term non-progressors display a greater number of Th17 cells than HIV-infected typical progressors.
Salgado M; Rallón NI; Rodés B; López M; Soriano V; Benito JM
Clin Immunol; 2011 May; 139(2):110-4. PubMed ID: 21367666
[TBL] [Abstract][Full Text] [Related]
4. A steady state of CD4+ T cell memory maturation and activation is established during primary subtype C HIV-1 infection.
Maenetje P; Riou C; Casazza JP; Ambrozak D; Hill B; Gray G; Koup RA; de Bruyn G; Gray CM
J Immunol; 2010 May; 184(9):4926-35. PubMed ID: 20363974
[TBL] [Abstract][Full Text] [Related]
5. Quantitative and qualitative assessment of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cell immunity to gag in HIV-1-infected individuals with differential disease progression: reciprocal interferon-gamma and interleukin-10 responses.
Ostrowski MA; Gu JX; Kovacs C; Freedman J; Luscher MA; MacDonald KS
J Infect Dis; 2001 Nov; 184(10):1268-78. PubMed ID: 11679915
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis of CD4+ and CD19+ cells during human immunodeficiency virus type 1 infection--correlation with clinical progression, viral load, and loss of humoral immunity.
Samuelsson A; Broström C; van Dijk N; Sönnerborg A; Chiodi F
Virology; 1997 Nov; 238(2):180-8. PubMed ID: 9400591
[TBL] [Abstract][Full Text] [Related]
7. HIV-specific IL-21 producing CD4+ T cells are induced in acute and chronic progressive HIV infection and are associated with relative viral control.
Yue FY; Lo C; Sakhdari A; Lee EY; Kovacs CM; Benko E; Liu J; Song H; Jones RB; Sheth P; Chege D; Kaul R; Ostrowski MA
J Immunol; 2010 Jul; 185(1):498-506. PubMed ID: 20519650
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection.
Musey L; Hughes J; Schacker T; Shea T; Corey L; McElrath MJ
N Engl J Med; 1997 Oct; 337(18):1267-74. PubMed ID: 9345075
[TBL] [Abstract][Full Text] [Related]
9. Memory CCR6+CD4+ T cells are preferential targets for productive HIV type 1 infection regardless of their expression of integrin β7.
Monteiro P; Gosselin A; Wacleche VS; El-Far M; Said EA; Kared H; Grandvaux N; Boulassel MR; Routy JP; Ancuta P
J Immunol; 2011 Apr; 186(8):4618-30. PubMed ID: 21398606
[TBL] [Abstract][Full Text] [Related]
10. Stable pattern of HIV-1 subtype C Gag-specific T-cell responses coincides with slow rate of CD4 T-cell decline in HIV-infected Ethiopians.
Tsegaye A; Ran L; Wolday D; Petros B; Nanlohy NM; Meles H; Girma M; Hailu E; Borghans J; Miedema F; van Baarle D
AIDS; 2007 Jan; 21(3):369-72. PubMed ID: 17255746
[TBL] [Abstract][Full Text] [Related]
11. ESAT-6- and CFP-10-specific Th1, Th22 and Th17 cells in tuberculous pleurisy may contribute to the local immune response against Mycobacterium tuberculosis infection.
Qiao D; Yang BY; Li L; Ma JJ; Zhang XL; Lao SH; Wu CY
Scand J Immunol; 2011 Apr; 73(4):330-7. PubMed ID: 21223348
[TBL] [Abstract][Full Text] [Related]
12. Antiretroviral therapy-induced dominant interleukin-2 HIV-1 Gag CD4+ T cell response: evidence of functional recovery of HIV-1-specific CD4+ T cells.
Tsalimalma K; Kordossis T; Choremi-Papadopoulou E
Scand J Immunol; 2011 Mar; 73(3):256-65. PubMed ID: 21204901
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of Th17 associated cytokines in chronic hepatitis C virus infection.
Sousa GM; Oliveira IS; Andrade LJ; Sousa-Atta ML; Paraná R; Atta AM
Cytokine; 2012 Oct; 60(1):138-42. PubMed ID: 22748467
[TBL] [Abstract][Full Text] [Related]
14. Differential immunogenicity of HIV-1 clade C proteins in eliciting CD8+ and CD4+ cell responses.
Ramduth D; Chetty P; Mngquandaniso NC; Nene N; Harlow JD; Honeyborne I; Ntumba N; Gappoo S; Henry C; Jeena P; Addo MM; Altfeld M; Brander C; Day C; Coovadia H; Kiepiela P; Goulder P; Walker B
J Infect Dis; 2005 Nov; 192(9):1588-96. PubMed ID: 16206073
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the frequency of interleukin (IL)-2-, interferon-gamma-, and IL-4-producing T cells in 2 diseases, human immunodeficiency virus types 1 and 2, with distinct clinical outcomes.
Sousa AE; Chaves AF; Loureiro A; Victorino RM
J Infect Dis; 2001 Sep; 184(5):552-9. PubMed ID: 11494161
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 dual infection is associated with faster CD4+ T-cell decline in a cohort of men with primary HIV infection.
Cornelissen M; Pasternak AO; Grijsen ML; Zorgdrager F; Bakker M; Blom P; Prins JM; Jurriaans S; van der Kuyl AC
Clin Infect Dis; 2012 Feb; 54(4):539-47. PubMed ID: 22157174
[TBL] [Abstract][Full Text] [Related]
17. Association of Gag-specific T lymphocyte responses during the early phase of human immunodeficiency virus type 1 infection and lower virus load set point.
Patke DS; Langan SJ; Carruth LM; Keating SM; Sabundayo BP; Margolick JB; Quinn TC; Bollinger RC
J Infect Dis; 2002 Oct; 186(8):1177-80. PubMed ID: 12355372
[TBL] [Abstract][Full Text] [Related]
18. Parallel assessment of Th17 cell frequencies by surface marker co-expression versus ex vivo IL-17 production in HIV-1 infection.
Dunay GA; Tóth I; Eberhard JM; Degen O; Tolosa E; van Lunzen J; Hauber J; Schulze Zur Wiesch J
Cytometry B Clin Cytom; 2016 Nov; 90(6):486-492. PubMed ID: 26666875
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 infection is characterized by profound depletion of CD161+ Th17 cells and gradual decline in regulatory T cells.
Prendergast A; Prado JG; Kang YH; Chen F; Riddell LA; Luzzi G; Goulder P; Klenerman P
AIDS; 2010 Feb; 24(4):491-502. PubMed ID: 20071976
[TBL] [Abstract][Full Text] [Related]
20. Loss of balance between T helper type 17 and regulatory T cells in chronic human immunodeficiency virus infection.
Li D; Chen J; Jia M; Hong K; Ruan Y; Liang H; Liu S; Zhang X; Zhao H; Peng H; Ma P; Shao Y
Clin Exp Immunol; 2011 Sep; 165(3):363-71. PubMed ID: 21707592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
